CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma

Name: CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma
Published: 2018
License: Public Domain

Cancer Targeted Technology · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

pet positron-emission-tomography renal-cell-carcinoma

renal cell carcinoma, rcc, prostate specific membrane antigen, psma, metastatic renal cancer, positron emission tomography, pet, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma

Related documents